Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

DEXTROSE AND SODIUM CH

Active
SPE2DP-26-T-4076Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Dextrose and Sodium Chloride Injection USP, provided in sterile, nonpyrogenic, single-dose containers, is intended for intravenous use only and contains 5 grams of hydrous dextrose and 0.45 grams of sodium chloride per 100 mL, with each bag holding 1 liter. The product is latex-free but contains DEHP and must be stored at controlled room temperature between 20 to 25°C, protected from excessive heat and freezing. Each package contains twelve 1-liter bags, and the solution must be visually inspected for clarity and intact seals prior to use. The item is regulated by the FDA with a nonextendable shelf life of 30 months and must be marked in full compliance with Medical Marking Standard No. 1 and MIL-STD-129. Packaging must adhere to DLA’s procurement requirements, with commercial packaging under ASTM D3951 unless otherwise superseded by DLA technical standards. The manufacturer is ICU Medical Sales, Inc., identified by NDC 00990-7926-09. The contract, issued under solicitation SPE2DP-26-T-4076, requires delivery of one box containing twelve 1-liter bags to FPO AP 96692 within 20 days of award, with zero variance allowed in quantity. Delivery is FOB destination, inspected and accepted at the delivery point. The item is assigned NSN 6505-00-116-1025 and is subject to covered defense information requirements. The contract specifies a required delivery date of July 14, 2026, with no alternate ship date provided. All shipments must follow DLA transport protocols and are tied to project JP5 TP 2, with primary point of contact Daniel Porter at the Department of Defense, Medical Supply Chain PHARM FSA.

General Info

Dextrose and sodium chloride injection, 1L bags, 12 per box, FOB destination, delivery by July 14, 2026, NSN 6505-00-116-1025

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

UNIT 100295 BOX 1, FPO, AP, 96692, US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4076 Medical Supply Chain Pharma FSA

PDF•rfq

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
DANIEL PORTER
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
DEXTROSE AND SODIUM CHLORIDE INJECTION
DEXTROSE AND SODIUM CHLORIDE INJECTION<(>,<)> USP. RX ONLY; STERILE AND
NONPYROGENIC. SINGLE-DOSE CONTAINER. LATEX-FREE; CONTAINS DEHP. FOR
INTRAVENOUS USE ONLY. CONTAINS ONE PORT. EACH 100 ML CONTAINS: HYDROUS
DEXTROSE USP 5 G SODIUM CHLORIDE USP 0.45 G WATER FOR INJECTION USP QS.
UNIT OF ISSUE IS A PACKAGE CONTAINING 12 EACH (BAGS/CONTAINERS). EACH
BAG OR CONTAINER CONTAINS 1,000 ML OR 1 LITER. STORE AT 20 TO 25°C (68
TO 77°F). [SEE USP CONTROLLED ROOM TEMPERATURE.] AVOID EXCESSIVE HEAT
AND PROTECT FROM FREEZING. USE ONLY IF THE SOLUTION IS CLEAR AND SEALS
ARE INTACT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS019: Shelf-life requirement RS001 for a TYPE I (CODE P) item with a shelf life of 30 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
ICU MEDICAL SALES, INC. 85RR5 P/N NDC00990-7926-09
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017445065 0001 BX 1.000
SPE2DP-26-T-4076
SECTION B
PR: 7017445065 PRLI: 0001 CONT’D
NSN/MATERIAL:6505001161025
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R21807
USS TOLEDO (SSN 769)
UNIT 100295 BOX 1
FPO AP 96692
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R21807
USS TOLEDO SSN 769
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
M/F: (TCN) R2180761893054
RDD: 777
PROJ: JP5 TP 2
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A41 DIST: E9B ADV: 2A FC: M7
Need Ship Date:00/00/0000 Original Required Delivery Date:07/14/2026
SPE2DP-26-T-4076
SECTION B
PR: 7017445065 PRLI: 0001 CONT’D

SPE2DP-26-T-4076 NSN/Part Number: 6505-00-116-1025 Quantity: 1 BX Purchase Request: 7017445065QTY: 1 Delivery: 20 days ADO

Similar Contracts

NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMIErythromycin Ophthalmic Ointment, USP, is a sterile, topical antibiotic product containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, formulated for ophthalmic use in single-dose tubes of 3.5 grams each. Each unit is packaged as a 24-tube unit, with a total shelf life of 36 months, requiring a minimum of 31 months of remaining shelf life upon delivery to the first government activity. The product must be stored at controlled room temperature between 15°C and 30°C (59°F–86°F), protected from excessive heat and freezing. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and adherence to the DLA Master List of Technical and Quality Requirements is mandatory, taking precedence over commercial standards such as ASTM D3951. Packaging must ensure protection from damage and enable safe, cost-effective delivery via common carrier to designated military installations, with shipment required by the fastest traceable means, excluding parcel post. The contract specifies four separate delivery lines totaling eight packages, with shipments directed to Fort Bragg, Fort Lewis, Fort Campbell, and additional Fort Bragg locations. Each delivery line has a five-day delivery window, FOB destination, and no quantity variance allowed. The item’s NSN is 6505011897090, and the manufacturer is PADAGIS US LLC with NDC 00574-4024-39. The product is regulated by the FDA, and buyers must route referrals through EBS for confirmation. All units must be palletized according to DLA packaging standards and clearly marked in accordance with the specified medical marking protocol. The solicitation number is SPE2DP-26-T-4083, with a required delivery date of July 14, 2026, and the contracting official is James McCullough of the Department of Defense’s Medical Supply Chain.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
Supplier of PLASMA CONTROL, NORMAL LEVEL (Medical Diagnostic Reagent)The contract is for the supply of a citrated plasma control solution designed for use in coagulation testing, specifically prothrombin time (PT) and activated partial thromboplastin time (APTT) assays. The product must be fully compatible with NS 6630-01-519-3589 analyzers and meet strict performance and stability standards required for diagnostic accuracy. Cold chain logistics are mandatory throughout transportation and storage to preserve product integrity, ensuring consistent quality from manufacturing to point of use. Regulatory compliance is a core requirement, with adherence to applicable medical device and in vitro diagnostic standards expected without exception. This is a subcontract under the Medical Supply Chain MD Surg FSF, managed by the Department of Defense, with performance obligated in San Antonio, Texas, at ZIP code 78226. The solicitation was posted on July 12, 2026, and responses are due by July 20, 2026. The North American Industry Classification System code 325412 applies, indicating classification within the manufacturing of in vitro diagnostic substances. All bidders must be prepared to meet the defense supply chain’s rigorous quality, delivery, and documentation protocols, with no exceptions to compliance or timeliness.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 17 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
FLUCONAZOLE TABLETSFluconazole tablets 150 mg are procured in individually sealed blister strips containing 12 tablets per unit, with the unit of issue defined as a package. Each unit must have a minimum shelf life of 24 months from the date of manufacture, and no more than three months may have elapsed between the date of manufacture and delivery to the government. The product must comply with the Medical Marking Standard No. 1, which supersedes MIL-STD-129, and all packaging and labeling must adhere to commercial standards ensuring protection from damage and safe transportation via common carrier. Mercury and mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the product, except for specific approved uses such as batteries or instrument components, which must be contained within a secondary boundary and meet NAVSEA 5100-003D requirements. The item is identified by NSN 6505013953039 and is subject to DLA’s Master List of Technical and Quality Requirements, with applicable revisions governed by the solicitation or award date. Deliveries must be made FOB destination within 20 days, with no tolerance for quantity variance. Inspection and acceptance occur at the point of delivery, and pre-delivery packaging must conform to MIL-STD-2073-1E. The contract is issued under solicitation SPE2DP-26-T-4081, with a response deadline of July 20, 2026, and is managed by the Department of Defense’s Medical Supply Chain PFS. The manufacturer is identified by NDC codes from Golden State Medical Supply Inc. and ANIP Acquisition Co.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANSPOVIDONE-IODINE CLEANSING SOLUTION, USP, containing 7.5% active ingredient, is specified for external use only and must be delivered in 1-gallon bottles with a unit of issue designated as BT. The product requires a minimum of 31 months of remaining shelf life upon delivery to the first government activity, with a total shelf life of 36 months, non-extendable, and must be stored at 25°C (77°F) with allowable excursions between 15°C and 30°C (59°F–86°F). Packaging must comply with DLA’s Packaging Requirements for Procurement and Medical Marking Standard No. 1, superseding MIL-STD-129, and all containers must be commercially sealed to prevent damage during transit. The product is classified as hazardous under Federal Standard No. 313-E, requiring submission of updated Safety Data Sheets and HCS-compliant labels aligned with OSHA’s Globally Harmonized System, along with employee training on these requirements. All shipments must be delivered FOB destination within 20 days, with no variance in quantity permitted, and inspected upon arrival. The item is regulated by the FDA and must be marked, labeled, and palletized according to DLA standards, with transportation directed via traceable means excluding parcel post. Delivery is scheduled for USS ZUMWALT DDG 1000 at FPO AP 96693, with the original required delivery date set for July 14, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 17 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
Supply of DPD Total Chlorine Reagent (Chemical Manufacturing)The contract mandates the manufacture and supply of DPD Total Chlorine Reagent in powder pillow form, specifically engineered to comply with federal and military standards for packaging, labeling, shelf life, and hazard communication. The product must meet stringent quality and safety criteria to ensure consistent performance in field and laboratory environments, with all materials and processes adhering to approved military specifications. The reagent is intended for use in water quality testing applications within military and government operations, requiring reliable and secure logistics to maintain efficacy over its defined shelf life. Performance is expected to be delivered to a military logistics location identified as FPO, ZIP 96693, with all shipments coordinated through the Department of Defense’s Medical Supply Chain. The contract is structured as a subcontract under NAICS code 325412, which classifies it under chemical manufacturing, and the solicitation closes on July 20, 2026. Interested parties must respond by the deadline to be considered for award, with all compliance documentation, including safety data sheets and certification of conformance, required to accompany proposals. The procurement is part of an ongoing effort to sustain critical test reagent supply chains for defense and medical operations.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 17 hours ago

DEADLINE

in 7 days
View Details